明德生物

- 002932

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
明德生物(002932) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入15,427.046,096.3474,953.6862,592.7753,756.03
营业收入15,427.046,096.3474,953.6862,592.7753,756.03
二、营业总成本21,216.9010,418.9872,014.6456,114.6445,335.03
营业成本6,877.613,640.9334,270.3132,372.2727,996.79
营业税金及附加70.3230.56225.02263.92229.28
销售费用5,493.292,407.6611,594.5111,548.038,210.24
管理费用3,748.661,884.3511,263.857,832.745,231.04
财务费用-495.44-262.72519.44-6,565.61-3,525.72
研发费用5,522.462,718.1914,141.5110,663.307,193.41
资产减值损失----------
公允价值变动收益63.71--458.91----
投资收益5,486.412,685.6912,055.032,966.792,927.71
其中:对联营企业和合营企业的投资收益-90.23---673.46-236.34-236.34
汇兑收益----------
三、营业利润7,010.773,437.2614,519.4521,934.7817,066.25
加:营业外收入17.7112.5287.7544.7122.07
减:营业外支出256.9537.56618.25560.29421.02
其中:非流动资产处置损失----------
四、利润总额6,771.533,412.2213,988.9521,419.2016,667.30
减:所得税费用1,294.38601.417,067.313,152.852,467.10
五、净利润5,477.152,810.826,921.6418,266.3414,200.20
归属于母公司所有者的净利润6,516.263,205.217,492.5914,529.9811,257.25
少数股东损益-1,039.10-394.39-570.953,736.362,942.95
六、每股收益
基本每股收益(元/股)0.28000.14000.33000.63000.4900
稀释每股收益(元/股)0.28000.14000.33000.63000.4800
七、其他综合收益--------372.22
八、综合收益总额5,477.152,810.826,921.6418,266.3414,572.42
归属于母公司所有者的综合收益总额6,516.263,205.217,492.5914,529.9811,629.47
归属于少数股东的综合收益总额-1,039.10-394.39-570.953,736.362,942.95
下载全部历史数据到excel中 返回页顶